These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18364263)

  • 1. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan.
    Fong Y; Chou SJ; Hung KF; Wu HT; Kao SY
    J Chin Med Assoc; 2008 Mar; 71(3):123-7. PubMed ID: 18364263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
    Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
    Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of elevated HER2/neu expression in epithelial dysplasia and oral squamous cell carcinoma in Iran.
    Seifi S; Shafaei SN; Nosrati K; Ariaeifar B
    Asian Pac J Cancer Prev; 2009; 10(4):661-4. PubMed ID: 19827890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
    AbdulMajeed AA; Dalley AJ; Farah CS
    Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
    Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
    J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas.
    Sawant SS; Vaidya Mm; Chaukar DA; Alam H; Dmello C; Gangadaran P; Kannan S; Kane S; Dange PP; Dey N; Ranganathan K; D'Cruz AK
    Oral Dis; 2014 Jul; 20(5):453-65. PubMed ID: 23865921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
    Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
    J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma.
    Hung KF; Chang CS; Liu CJ; Lui MT; Cheng CY; Kao SY
    J Oral Pathol Med; 2006 Nov; 35(10):589-94. PubMed ID: 17032390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
    J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
    Nitta T; Sugihara K; Tsuyama S; Murata F
    Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis.
    Hung KF; Lin SC; Liu CJ; Chang CS; Chang KW; Kao SY
    J Oral Pathol Med; 2003 Sep; 32(8):461-7. PubMed ID: 12901727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
    Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.
    Torres-Rendon A; Roy S; Craig GT; Speight PM
    Br J Cancer; 2009 Apr; 100(7):1128-34. PubMed ID: 19293805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis resistance-related ABCB5 and DNaseX (Apo10) expression in oral carcinogenesis.
    Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Reinert S
    Acta Odontol Scand; 2015 Jul; 73(5):336-42. PubMed ID: 25234444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HER-2/neu in Oral Squamous Cell Carcinoma.
    Mirza S; Hadi N; Pervaiz S; Zeb Khan S; Mokeem SA; Abduljabbar T; Al-Hamoudi N; Vohra F
    Asian Pac J Cancer Prev; 2020 May; 21(5):1465-1470. PubMed ID: 32458657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.